Saudi Arabia External Counterpulsation Devices Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Description
Saudi Arabia External Counterpulsation Devices Market Overview
The Saudi Arabia External Counterpulsation Devices Market is valued at USD 140 million, based on a five-year historical analysis and aligned with the scale of the country’s cardiovascular disease burden and advanced cardiac care capacity. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, including ischemic heart disease and heart failure, rising prevalence of risk factors such as obesity, diabetes, hypertension and dyslipidemia, and growing awareness about non?invasive treatment options. Advancements in medical technology, expanding cardiac service lines in tertiary hospitals, and initiatives under Saudi Vision 2030 to strengthen non?communicable disease management have further accelerated adoption, as healthcare providers seek effective solutions for patients with chronic and refractory heart conditions. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure, higher concentration of tertiary and specialized cardiac centers, and greater availability of interventional cardiology and heart failure programs. These urban centers host major governmental and private hospitals, attract referrals from across the Kingdom, and increasingly invest in comprehensive cardiovascular disease management, thereby driving the demand for external counterpulsation devices as an adjunctive, non?invasive therapy. In 2023, the Saudi Food and Drug Authority (SFDA) continued implementing and enforcing the Medical Devices Interim Regulation, issued by the SFDA Board of Directors and first promulgated in 2008, along with its Executive Regulations, to enhance the quality and safety of medical devices, including external counterpulsation systems. This regulatory framework requires that all medical devices be registered with SFDA, comply with essential safety and performance principles, and obtain marketing authorization based on conformity assessment, technical documentation, and, where applicable, quality management system certification before being placed on the Saudi market or used in healthcare facilities. These measures ensure that patients receive safe and effective treatments and that healthcare providers use devices that meet internationally harmonized standards.
Saudi Arabia External Counterpulsation Devices Market Segmentation
By Device Type: The market is segmented into various device types, including EECP (Enhanced External Counterpulsation) Systems, External Counterpulsation Therapy Systems (Non-EECP), Single-Channel Systems, and Multi-Channel Systems. Among these, EECP systems are leading the market due to their documented effectiveness in improving symptoms and exercise tolerance in patients with refractory angina and chronic heart failure who are not suitable for further revascularization. The growing preference for non-invasive treatment options, the high and rising prevalence of cardiovascular diseases in Saudi Arabia, and the focus on optimizing chronic disease management under national non?communicable disease strategies are driving the demand for these advanced systems. By Mobility: The market is categorized into Stationary Systems and Portable / Mobile Systems. Stationary systems dominate the market due to their widespread deployment in hospitals and cardiac specialty centers, where they are preferred for their robustness, higher throughput, integration with hospital monitoring systems, and suitability for managing complex cardiovascular cases in supervised settings. However, the demand for portable systems is increasing as they offer flexibility for outpatient clinics, potential use in step?down or rehabilitation environments, and support the broader trend toward home?based and community cardiac care for stable chronic patients in Saudi Arabia.
Saudi Arabia External Counterpulsation Devices Market Market Opportunities
The Saudi Arabia External Counterpulsation Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Vasomedical Inc., VasoMedical Global Corp., PSK-Health (PSK Healthcare), Renew Group Pte Ltd, Chongqing PSK-Health Sci-Tech Development Co., Ltd., Guangzhou SunHope MedTech Co., Ltd., Royal Philips, GE HealthCare Technologies Inc., Siemens Healthineers AG, Nihon Kohden Corporation, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Biotronik SE & Co. KG, Local Distributors & Service Providers in Saudi Arabia contribute to innovation, geographic expansion, and service delivery in this space. Vasomedical Inc. 1987 Westbury, New York, USA
VasoMedical Global Corp. 2001 Plainview, New York, USA
PSK-Health (PSK Healthcare)
2006
Singapore
Renew Group Pte Ltd
2011
Singapore
Chongqing PSK-Health Sci-Tech Development Co., Ltd. 2008 Chongqing, China
Company
Establishment Year
Headquarters
Company Size (Revenues in Saudi Arabia, USD Million)
3-Year Revenue CAGR in Saudi Arabia External Counterpulsation Segment (%)
Installed Base in Saudi Arabia (Number of Systems)
Annual Procedure Volume Supported (Number of EECP Sessions)
Market Share by Installed Base (%)
Average Selling Price per System (USD)
Saudi Arabia External Counterpulsation Devices Market Industry Analysis
Growth Drivers
Increasing Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases in Saudi Arabia is alarming, with approximately 40% of deaths attributed to heart-related issues, according to the Saudi Ministry of Health. This statistic underscores the urgent need for effective treatment options, including external counterpulsation devices. The rising incidence of conditions such as hypertension and coronary artery disease is driving demand for innovative therapies, positioning these devices as critical components in the healthcare landscape. Rising Awareness About Non-Invasive Treatment Options: Awareness of non-invasive treatment options is growing among healthcare professionals and patients alike. In future, it is estimated that over 60% of patients prefer non-invasive therapies due to their lower risk profiles. This shift is supported by educational campaigns from health authorities and medical institutions, which highlight the benefits of external counterpulsation devices. As a result, the market is witnessing increased adoption rates, contributing to overall growth. Technological Advancements in Medical Devices: The Saudi healthcare sector is experiencing rapid technological advancements, with investments exceeding SAR 12 billion in medical technology in future. Innovations in external counterpulsation devices, such as improved efficacy and user-friendly designs, are enhancing treatment outcomes. These advancements are attracting healthcare providers to adopt these devices, thereby expanding their market presence. The integration of smart technologies further supports this growth by enabling better patient monitoring and management.
Market Challenges
High Cost of External Counterpulsation Devices: The high cost of external counterpulsation devices remains a significant barrier to market growth. Prices can range from SAR 120,000 to SAR 280,000 per unit, making them less accessible for many healthcare facilities, particularly in rural areas. This financial constraint limits the widespread adoption of these devices, hindering potential market expansion. As a result, healthcare providers may opt for less effective, lower-cost alternatives, impacting patient outcomes. Limited Reimbursement Policies: The lack of comprehensive reimbursement policies for external counterpulsation devices poses a challenge for market penetration. Currently, only 35% of healthcare providers in Saudi Arabia receive reimbursement for these treatments, according to the Saudi Health Insurance Council. This limited coverage discourages healthcare facilities from investing in these devices, as the financial burden falls on patients. Consequently, this challenge restricts the growth potential of the external counterpulsation devices market.
Saudi Arabia External Counterpulsation Devices Market Future Outlook
The future of the external counterpulsation devices market in Saudi Arabia appears promising, driven by increasing healthcare investments and a growing focus on preventive care. As the government continues to enhance healthcare infrastructure, the adoption of advanced medical technologies is expected to rise. Additionally, the integration of telemedicine with treatment devices will likely improve patient access and monitoring. These trends indicate a robust market environment, fostering innovation and collaboration among stakeholders in the healthcare sector.
Market Opportunities
Expansion of Healthcare Infrastructure: The Saudi government is investing heavily in healthcare infrastructure, with plans to allocate SAR 60 billion for new hospitals and clinics in future. This expansion will create opportunities for the adoption of external counterpulsation devices, as more facilities will be equipped to offer advanced cardiovascular treatments, thereby increasing market penetration. Increasing Demand for Home Healthcare Solutions: The demand for home healthcare solutions is on the rise, with an estimated 30% of patients preferring at-home treatments in future. This trend presents a significant opportunity for external counterpulsation devices, as manufacturers can develop portable and user-friendly models tailored for home use, enhancing patient convenience and adherence to treatment protocols.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Saudi Arabia External Counterpulsation Devices Market is valued at USD 140 million, based on a five-year historical analysis and aligned with the scale of the country’s cardiovascular disease burden and advanced cardiac care capacity. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, including ischemic heart disease and heart failure, rising prevalence of risk factors such as obesity, diabetes, hypertension and dyslipidemia, and growing awareness about non?invasive treatment options. Advancements in medical technology, expanding cardiac service lines in tertiary hospitals, and initiatives under Saudi Vision 2030 to strengthen non?communicable disease management have further accelerated adoption, as healthcare providers seek effective solutions for patients with chronic and refractory heart conditions. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure, higher concentration of tertiary and specialized cardiac centers, and greater availability of interventional cardiology and heart failure programs. These urban centers host major governmental and private hospitals, attract referrals from across the Kingdom, and increasingly invest in comprehensive cardiovascular disease management, thereby driving the demand for external counterpulsation devices as an adjunctive, non?invasive therapy. In 2023, the Saudi Food and Drug Authority (SFDA) continued implementing and enforcing the Medical Devices Interim Regulation, issued by the SFDA Board of Directors and first promulgated in 2008, along with its Executive Regulations, to enhance the quality and safety of medical devices, including external counterpulsation systems. This regulatory framework requires that all medical devices be registered with SFDA, comply with essential safety and performance principles, and obtain marketing authorization based on conformity assessment, technical documentation, and, where applicable, quality management system certification before being placed on the Saudi market or used in healthcare facilities. These measures ensure that patients receive safe and effective treatments and that healthcare providers use devices that meet internationally harmonized standards.
Saudi Arabia External Counterpulsation Devices Market Segmentation
By Device Type: The market is segmented into various device types, including EECP (Enhanced External Counterpulsation) Systems, External Counterpulsation Therapy Systems (Non-EECP), Single-Channel Systems, and Multi-Channel Systems. Among these, EECP systems are leading the market due to their documented effectiveness in improving symptoms and exercise tolerance in patients with refractory angina and chronic heart failure who are not suitable for further revascularization. The growing preference for non-invasive treatment options, the high and rising prevalence of cardiovascular diseases in Saudi Arabia, and the focus on optimizing chronic disease management under national non?communicable disease strategies are driving the demand for these advanced systems. By Mobility: The market is categorized into Stationary Systems and Portable / Mobile Systems. Stationary systems dominate the market due to their widespread deployment in hospitals and cardiac specialty centers, where they are preferred for their robustness, higher throughput, integration with hospital monitoring systems, and suitability for managing complex cardiovascular cases in supervised settings. However, the demand for portable systems is increasing as they offer flexibility for outpatient clinics, potential use in step?down or rehabilitation environments, and support the broader trend toward home?based and community cardiac care for stable chronic patients in Saudi Arabia.
Saudi Arabia External Counterpulsation Devices Market Market Opportunities
The Saudi Arabia External Counterpulsation Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Vasomedical Inc., VasoMedical Global Corp., PSK-Health (PSK Healthcare), Renew Group Pte Ltd, Chongqing PSK-Health Sci-Tech Development Co., Ltd., Guangzhou SunHope MedTech Co., Ltd., Royal Philips, GE HealthCare Technologies Inc., Siemens Healthineers AG, Nihon Kohden Corporation, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Biotronik SE & Co. KG, Local Distributors & Service Providers in Saudi Arabia contribute to innovation, geographic expansion, and service delivery in this space. Vasomedical Inc. 1987 Westbury, New York, USA
VasoMedical Global Corp. 2001 Plainview, New York, USA
PSK-Health (PSK Healthcare)
2006
Singapore
Renew Group Pte Ltd
2011
Singapore
Chongqing PSK-Health Sci-Tech Development Co., Ltd. 2008 Chongqing, China
Company
Establishment Year
Headquarters
Company Size (Revenues in Saudi Arabia, USD Million)
3-Year Revenue CAGR in Saudi Arabia External Counterpulsation Segment (%)
Installed Base in Saudi Arabia (Number of Systems)
Annual Procedure Volume Supported (Number of EECP Sessions)
Market Share by Installed Base (%)
Average Selling Price per System (USD)
Saudi Arabia External Counterpulsation Devices Market Industry Analysis
Growth Drivers
Increasing Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases in Saudi Arabia is alarming, with approximately 40% of deaths attributed to heart-related issues, according to the Saudi Ministry of Health. This statistic underscores the urgent need for effective treatment options, including external counterpulsation devices. The rising incidence of conditions such as hypertension and coronary artery disease is driving demand for innovative therapies, positioning these devices as critical components in the healthcare landscape. Rising Awareness About Non-Invasive Treatment Options: Awareness of non-invasive treatment options is growing among healthcare professionals and patients alike. In future, it is estimated that over 60% of patients prefer non-invasive therapies due to their lower risk profiles. This shift is supported by educational campaigns from health authorities and medical institutions, which highlight the benefits of external counterpulsation devices. As a result, the market is witnessing increased adoption rates, contributing to overall growth. Technological Advancements in Medical Devices: The Saudi healthcare sector is experiencing rapid technological advancements, with investments exceeding SAR 12 billion in medical technology in future. Innovations in external counterpulsation devices, such as improved efficacy and user-friendly designs, are enhancing treatment outcomes. These advancements are attracting healthcare providers to adopt these devices, thereby expanding their market presence. The integration of smart technologies further supports this growth by enabling better patient monitoring and management.
Market Challenges
High Cost of External Counterpulsation Devices: The high cost of external counterpulsation devices remains a significant barrier to market growth. Prices can range from SAR 120,000 to SAR 280,000 per unit, making them less accessible for many healthcare facilities, particularly in rural areas. This financial constraint limits the widespread adoption of these devices, hindering potential market expansion. As a result, healthcare providers may opt for less effective, lower-cost alternatives, impacting patient outcomes. Limited Reimbursement Policies: The lack of comprehensive reimbursement policies for external counterpulsation devices poses a challenge for market penetration. Currently, only 35% of healthcare providers in Saudi Arabia receive reimbursement for these treatments, according to the Saudi Health Insurance Council. This limited coverage discourages healthcare facilities from investing in these devices, as the financial burden falls on patients. Consequently, this challenge restricts the growth potential of the external counterpulsation devices market.
Saudi Arabia External Counterpulsation Devices Market Future Outlook
The future of the external counterpulsation devices market in Saudi Arabia appears promising, driven by increasing healthcare investments and a growing focus on preventive care. As the government continues to enhance healthcare infrastructure, the adoption of advanced medical technologies is expected to rise. Additionally, the integration of telemedicine with treatment devices will likely improve patient access and monitoring. These trends indicate a robust market environment, fostering innovation and collaboration among stakeholders in the healthcare sector.
Market Opportunities
Expansion of Healthcare Infrastructure: The Saudi government is investing heavily in healthcare infrastructure, with plans to allocate SAR 60 billion for new hospitals and clinics in future. This expansion will create opportunities for the adoption of external counterpulsation devices, as more facilities will be equipped to offer advanced cardiovascular treatments, thereby increasing market penetration. Increasing Demand for Home Healthcare Solutions: The demand for home healthcare solutions is on the rise, with an estimated 30% of patients preferring at-home treatments in future. This trend presents a significant opportunity for external counterpulsation devices, as manufacturers can develop portable and user-friendly models tailored for home use, enhancing patient convenience and adherence to treatment protocols.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
100 Pages
- 1. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Size (in USD Bn), 2019-2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing prevalence of cardiovascular diseases
- 3.1.2 Advancements in medical technology and device efficacy
- 3.1.3 Rising healthcare expenditure and government initiatives
- 3.1.4 Growing awareness of non-invasive treatment options
- 3.2. Restraints
- 3.2.1 High cost of external counterpulsation devices
- 3.2.2 Limited reimbursement policies for new medical technologies
- 3.2.3 Lack of trained professionals for device operation
- 3.2.4 Regulatory hurdles in device approval
- 3.3. Opportunities
- 3.3.1 Expansion of healthcare infrastructure in Saudi Arabia
- 3.3.2 Increasing demand for cardiac rehabilitation services
- 3.3.3 Potential for partnerships with international medical device companies
- 3.3.4 Growth in telemedicine and remote monitoring solutions
- 3.4. Trends
- 3.4.1 Shift towards patient-centric healthcare solutions
- 3.4.2 Integration of AI and machine learning in device functionality
- 3.4.3 Focus on preventive healthcare and early diagnosis
- 3.4.4 Rising interest in clinical research and trials for new devices
- 3.5. Government Regulation
- 3.5.1 Compliance with Saudi Food and Drug Authority (SFDA) regulations
- 3.5.2 Standards for medical device safety and efficacy
- 3.5.3 Guidelines for clinical trials and product approvals
- 3.5.4 Policies promoting local manufacturing of medical devices
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Segmentation, 2024
- 4.1. By Product Type (in Value %)
- 4.1.1 Pneumatic Devices
- 4.1.2 Electromechanical Devices
- 4.1.3 Hybrid Devices
- 4.1.4 Portable Devices
- 4.1.5 Others
- 4.2. By End-User (in Value %)
- 4.2.1 Hospitals
- 4.2.2 Cardiac Rehabilitation Centers
- 4.2.3 Home Care Settings
- 4.2.4 Clinics
- 4.3. By Technology (in Value %)
- 4.3.1 Traditional Counterpulsation
- 4.3.2 Advanced Counterpulsation
- 4.4. By Region (in Value %)
- 4.4.1 Central Region
- 4.4.2 Eastern Region
- 4.4.3 Western Region
- 4.4.4 Northern Region
- 4.4.5 Southern Region
- 4.5. By Price Tier (in Value %)
- 4.5.1 Premium
- 4.5.2 Mid-range
- 4.5.3 Economy
- 4.6. By Application (in Value %)
- 4.6.1 Heart Failure
- 4.6.2 Angina Pectoris
- 4.6.3 Myocardial Infarction
- 4.6.4 Others
- 5. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 CardioComm Solutions
- 5.1.2 ZOLL Medical Corporation
- 5.1.3 Abiomed, Inc.
- 5.1.4 BTL Industries
- 5.1.5 Medtronic plc
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Production Capacity
- 6. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Regulatory Framework
- 6.1. Medical Device Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Future Size (in USD Bn), 2025-2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Saudi Arabia External Counterpulsation Devices Size Share Growth Drivers Trends Opportunities & – Market Future Segmentation, 2030
- 8.1. By Product Type (in Value %)
- 8.2. By End-User (in Value %)
- 8.3. By Technology (in Value %)
- 8.4. By Price Tier (in Value %)
- 8.5. By Application (in Value %)
- 8.6. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
